Abstract:Sir,We read with great interest the article published in Brain by Tezenas du Montcel et al. (2014) reporting modifying factors of age-at-onset in 1255 individuals affected with spinocerebellar ataxia (SCA) types 1, 2, 3, 6 and 7, recruited through the European Consortium on Spinocerebellar Ataxias (EUROSCA). We would like to report our findings on genetic modifiers and age-at-onset in 802 Chinese Han patients (429 males, 373 females) with Machado-Joseph disease (MJD/SCA3), on behalf of the Chinese Clinical Research Cooperative Group for Spinocerebellar Ataxias (CCRCG-SCA). Our study was approved by the ethics committee of Xiangya Hospital, Central South University. Blood samples were collected after written informed consent from all subjects. All MJD patients were genotyped for ATXN3 and nine other polyQ-related genes ( ATXN1 , ATXN2 , CACNA1A , ATXN7 , TBP , ATN1 , KCNN3 , RAI1 and HTT ). None of the MJD patients was a ‘homozygote’ (i.e. bearing two expanded alleles).We used a similar statistical strategy as described by the EUROSCA consortium (Tezenas du Montcel et al. , 2014). For some polyQ-related genes ( ATXN1 , TBP , ATN1 and HTT ), the sizes of the shorter and the longer alleles were considered (separately) as continuous variables; given the skewed distribution of allele size in the other genes ( ATXN2 , ATXN3 , ATXN7 , CACNA1A and RAI1 ) these were classified as short, short-medium, medium or long (Table 1). The interaction between both alleles, their mean length and the size difference between alleles at each locus were also considered as dependent variables. View this table:Table 1 Classification of polyQ-related normal alleles according to the number of CAG repeatsThe logarithmically transformed age-at-onset was treated as a dependent variable with homoscedasticity. Linear regression analysis (linear and quadratic effects) was performed to estimate the effect on age-at-onset of the expanded allele at ATXN3. Different models were then …

A modifier of Huntington's disease onset at the MLH1 locus

Genetic modifiers of somatic expansion and clinical phenotypes in Huntington's disease reveal shared and tissue-specific effects

Chromosome substitution strain assessment of a Huntington's disease modifier locus

Msh3 and Pms1 Set Neuronal CAG-repeat Migration Rate to Drive Selective Striatal and Cortical Pathogenesis in HD Mice

Huntingtin-associated Protein-1 is a Modifier of the Age-at-onset of Huntington's Disease.

Identification of genetic modifiers of Huntington's disease somatic CAG repeat instability by in vivo CRISPR-Cas9 genome editing

Identification of genetic modifiers of Huntington′s disease somatic CAG repeat instability by in vivo CRISPR-Cas9 genome editing

(CAG)n loci as genetic modifiers of age-at-onset in patients with Machado-Joseph disease from mainland China.

A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort

Beyond CAG Repeats: The Multifaceted Role of Genetics in Huntington Disease

Ccg Polymorphisms in the Huntingtin Gene Have No Effect on the Pathogenesis of Patients with Huntington'S Disease in Mainland Chinese Families

Attenuated huntingtin gene CAG nucleotide repeat size in individuals with Lynch syndrome

Therapeutic validation of MMR-associated genetic modifiers in a human ex vivo model of Huntington disease

Clinical and Genetic Profiles in Chinese Patients with Huntington's Disease: A Ten-year Multicenter Study in China.

Combined epigenetic/genetic study identified an ALS age of onset modifier.

Splice modulators target PMS1 to reduce somatic expansion of the Huntington’s disease-associated CAG repeat

IT15 gene analysis in two pedigrees of Huntington's disease]

Huntington’s Disease: Relationship Between Phenotype and Genotype

Loss of CAA Interruption and Intergenerational CAG Instability in Chinese Patients with Huntington’s Disease

Haplotype Analysis Encompassing HTT Gene in Chinese Patients with Huntington's Disease

DNA methylation study of Huntington’s disease and motor progression in patients and in animal models